Skip to main content

The Tasmanian devil's cancer

A week or so ago, Ann Maree Pearce, a government cytogeneticist from Australia's island state, Tasmania, and colleagues said in a Nature news report that a nasty facial cancer affecting the Tasmanian devil population, dubbed Devil Facial Tumour Disease, was in fact an infective cell line being passed between the ferocious, foxed-sized scavengers via bites and so on. At the linkurl:18th Lorne Cancer Conference Erskine on the Beach;https://www.the-scientist.com/blog/display/23110/ in Lorne, Austra

Written byStephen Pincock
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
A week or so ago, Ann Maree Pearce, a government cytogeneticist from Australia's island state, Tasmania, and colleagues said in a Nature news report that a nasty facial cancer affecting the Tasmanian devil population, dubbed Devil Facial Tumour Disease, was in fact an infective cell line being passed between the ferocious, foxed-sized scavengers via bites and so on. At the linkurl:18th Lorne Cancer Conference Erskine on the Beach;https://www.the-scientist.com/blog/display/23110/ in Lorne, Australia, Pearce explained how she had initially tried performing a chromosomal analysis of samples taken from numerous devils across the island in the hope of spotting a common breakpoint. She found to her surprise that they were identical in every case, regardless of whether the host animal was male or female. It was only when they came across Errol (named in honor of the famous Tasmanian actor Errol Flynn) a devil with a pericentric inversion on chromosome 5, that the penny dropped. The inverted 5 was not present in the facial growth, Pearce explained. 'So Errol's cancer had to come from someone else.' The tumour is fatal and spreading fast in the Tasmanian devil population, she said, thanks to their endless fighting and 'rough foreplay.' The hope is that a vaccine can be developed before the population dwindles any further.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo